AQP4 |
aquaporin 4 |
ATP |
adenosine triphosphate |
BAX |
Bcl-associated X protein |
BBB |
blood brain barrier |
CAMKII |
calmodulin dependent protein kinase-II |
CCI |
controlled cortical impact |
CNS |
central nervous system |
CSF |
cerebrospinal fluid |
CT |
computed tomography |
DAI |
diffuse axonal injury |
FPI |
fluid percussion injury |
FRET |
Förster resonance energy transfer |
GCS |
Glasgow Coma Scale |
GFAP |
glial fibrillary acidic protein |
GLI |
glibenclamide |
GOS |
Glasgow Outcome Scale |
IMPACT |
International Mission for Prognosis and Clinical Trial design in TBI |
LHI |
large hemispheric infarction |
MMP-9 |
matrix metalloproteinase-9 |
MRI |
magnetic resonance imaging |
NFAT |
nuclear factor of activated T-cells |
NO |
nitric oxide |
NOS2 |
nitric oxide synthase-2 |
OBTT |
operation brain trauma therapy |
PAR1 |
protease activated receptor 1 |
SAH |
subarachnoid hemorrhage |
SCI |
spinal cord injury |
Sp1 |
specificity protein 1 |
SUR1 |
Sulfonylurea receptor 1 |
TBI |
traumatic brain injury |
TLR4 |
toll like receptor 4 |
tPA |
tissue plasminogen activator |
TRPM4 |
transient receptor potential melastatin 4 |
SUR1±TRPM4 |
SUR1 with or without TRPM4 |
TUNEL |
terminal deoxynucleotidyl transferase dUTP nick end labeling |
TXA |
tranexamic acid |
UCHL1 |
ubiquitin C-terminal hydrolase-L1 |
ZO-1 |
zona occludens 1 |